Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-07-02 4:05 pm Purchase | 13G | ODONATE THERAPEUTICS INC ODT | Ikarian Capital LLC | 1,986,412 5.2% | 1,986,412 (New Position) | View |
| 2021-04-08 09:02 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital LLC | 2,624,988 11.1% | 1,798,564 (+217.63%) | View |
| 2021-04-07 5:25 pm Purchase | 13G | MILLENDO THERAPEUTICS INC MLND | Ikarian Capital LLC | 1,348,021 7.1% | 1,348,021 (New Position) | View |
| 2021-02-16 08:33 am Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,716,840 17.8% | 554,291 (+25.63%) | View |
| 2021-02-16 08:31 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital LLC | 1,063,961 5.9% | 117,356 (+12.40%) | View |
| 2021-02-16 07:49 am Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Ikarian Capital LLC | 815,364 6.3% | 30,000 (+3.82%) | View |
| 2021-02-12 4:35 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Ikarian Capital LLC | 1,466,147 5.4% | 392,500 (+36.56%) | View |
| 2021-02-12 4:32 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | Ikarian Capital LLC | 1,364,990 3.5% | -227,449 (-14.28%) | View |
| 2021-02-12 4:32 pm Sale | 13G | STRONGBRIDGE BIOPHARMA PLC SHS SBBP | Ikarian Capital LLC | 2,440,028 3.6% | -802,759 (-24.76%) | View |
| 2021-02-12 4:31 pm Purchase | 13G | YUMANITY THERAPEUTICS INC YMTX | Ikarian Capital LLC | 132,514 1.3% | 132,514 (New Position) | View |
| 2021-02-12 4:31 pm Sale | 13G | VERASTEM, INC. VSTM | Ikarian Capital LLC | 2,254,591 1.3% | -2,797,284 (-55.37%) | View |
| 2021-02-12 4:31 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital LLC | 649,542 5.8% | 649,542 (New Position) | View |
| 2021-01-11 5:25 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital LLC | 1,836,545 6.2% | 1,836,545 (New Position) | View |
| 2021-01-11 5:24 pm Purchase | 13G | LIFESCI ACQUISITION II CORP LSAQ | Ikarian Capital LLC | 512,450 6.4% | 512,450 (New Position) | View |
| 2021-01-08 9:59 pm Purchase | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Ikarian Capital LLC | 400,000 8.2% | 400,000 (New Position) | View |
| 2021-01-08 9:59 pm Purchase | 13G | AERPIO PHARMACEUTICALS INC ARPO | Ikarian Capital LLC | 475,778 1% | 475,778 (New Position) | View |
| 2021-01-08 9:57 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 500,000 9.9% | 500,000 (New Position) | View |
| 2020-12-30 5:26 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital LLC | 826,424 5.1% | 826,424 (New Position) | View |
| 2020-12-30 5:26 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Ikarian Capital LLC | 785,364 6.1% | 785,364 (New Position) | View |
| 2020-11-17 9:43 pm Purchase | 13G | PROTEOSTASIS THERAPEUTICS INC PTI | Ikarian Capital LLC | 2,650,347 5.1% | 2,650,347 (New Position) | View |